ArticleCancers2023

First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study.

Keiko Tanimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.